Alphabet's Verily closes its medical device division and lays off staff
Alphabet's Verily, a division of the tech giant, has shut down its medical device division and laid off an unspecified number of employees. This decision is part of Alphabet's 2023 strategic shift, which has seen the company cut 12,000 positions across multiple divisions while focusing more on AI and data infrastructure. The medical device division, which had been one of Verily's "moonshot" businesses, was involved in areas ranging from connected diabetes therapies to robot surgery. While the division's achievements were highlighted by CEO Stephen Gillett, it seems the division was not a profit maker for Alphabet. Moving forward, Verily will now focus on its "core mission" of precision health, data, and AI. The company's spokesperson stated that the medical devices division will no longer be supported, and the cuts are a continuation of Alphabet's broader strategic realignment.
Source: For the complete article, please visit the original source link below.
